Influence of FPGS, ABCC4, SLC29A1, and MTHFR genes on the pharmacogenomics of fluoropyrimidines in patients with gastrointestinal cancer from the Brazilian Amazon.
Marianne Rodrigues FernandesJuliana Carla Gomes RodriguesElizabeth Ayres Fragoso DobbinLucas Favacho PastanaDanielle Feio da CostaWilliams Fernandes BarraAntônio André Conde ModestoPaula Baraúna de AssumpçãoArtur Luiz da Costa da SilvaSidney Emanuel Batista Dos SantosRommel Mario Rodríguez BurbanoPaulo Pimentel de AssumpçãoNey Pereira Carneiro Dos SantosPublished in: Cancer chemotherapy and pharmacology (2021)
Four polymorphisms of the ABCC4, FPGS, SLC29A1, and MTHFR genes are likely to be potential predictive biomarkers for precision medicine in fluoropyrimidine-based treatments in the population of the Brazilian Amazon, which is constituted by a unique genetic background.